Master Multimodal AI for Drug Discovery: AlphaFold to Generative Therapeutics in 4 weeks through hands-on, project-based online training with DSTC.
Drug Discovery & Pharmaceutical Sciences
Module-by-module breakdown of Multimodal AI for Drug Discovery: AlphaFold to Generative Therapeutics, from foundations to a certified capstone project.
Structure
โข AlphaFold and the AlphaFold Database: what is available without running anything
โข pLDDT and PAE together, and why a low-confidence loop is often genuine disorder
โข AlphaFold-Multimer for complexes and the sharply lower reliability of interfaces
Modalities
โข Sequence, graph, structure and text encoders and what each captures
โข Transcriptomic and clinical data as additional evidence about a target
โข Fusion strategies โ early, late and cross-attention โ and their failure modes
Generation
โข SMILES, graph and 3D diffusion generators compared on validity and novelty
โข Structure-conditioned generation and the tendency to produce unsynthesisable output
โข Synthetic accessibility scoring and retrosynthesis checks as a required gate
Proteins
โข RFdiffusion and ProteinMPNN in the design-then-sequence workflow
โข In silico filtering of designs before any wet-lab commitment
โข Reported success rates and why most designed binders still fail
Judgement
โข Benchmark leakage and why held-out targets matter more than headline metrics
โข Where multimodal models genuinely beat single-modality baselines, and where they do not
โข Translating a computational hit into a testable experimental plan
e-Certificate and e-Marksheet issued on successful completion.